MitoSciences awarded $590,000 to support development of companion diagnostic tests for antiviral drugs

January 18, 2016

The article examines the diversification strategies of large pharmaceutical companies, including efforts to "expand geographically, especially into emerging markets[,] ?? increase sales of products other than patented prescription medicines[, and] ?? experiment with greater flexibility in pricing in different countries and with ways to ensure drugs provide value for money." The piece includes comments by the heads of large pharmaceutical companies and pharmaceutical analysts (Jack, 5/12).

This article is republished with kind permission from our friends at The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is published for Kaisernetwork, a free service of The Henry J. Kaiser Family Foundation. 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.